NCT03142334 · Interventional trial
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
Overall registry status Completed
Phase 3
Conditions Renal Cell Carcinoma
Delaware Valley sites
- Abramson Cancer Center ( Site 0010) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory